Glycemic control and sliding scale insulin use in medical inpatients with diabetes mellitus

被引:195
|
作者
Queale, WS
Seidler, AJ
Brancati, FL
机构
[1] JOHNS HOPKINS MED INST, WELSH CTR PREVENT EPIDEMIOL & CLIN RES, BALTIMORE, MD 21205 USA
[2] JOHNS HOPKINS MED INST, DEPT MED, BALTIMORE, MD 21205 USA
关键词
D O I
10.1001/archinte.157.5.545
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To identify predictors of hypoglycemic and hyperglycemic episodes in hospitalized patients with diabetes with special attention to the effectiveness of sliding scale insulin regimens. Design: Prospective cohort study. Setting: Urban university hospital. Participants: One hundred seventy-one adults with diabetes mellitus as a comorbid condition admitted consecutively to medical inpatient services during a 7-week period. Measurements: Demographic, clinical, and laboratory data from inpatient medical records. Main Outcomes: Rates of hypoglycemic (capillary blood glucose, less than or equal to 3.3 mmol/L [less than or equal to 60 mg/dL]) and hyperglycemic (capillary blood glucose, greater than or equal to 16.5 mmol/L [greater than or equal to 300 mg/dL]) episodes. Results: Of the patients, 23% experienced hypoglycemic episodes, and 40% experienced hyperglycemic episodes. The overall rates of hypoglycemic and hyperglycemic episodes were 3.4 and 9.8 per 100 capillary blood glucose measurements, respectively. Independent predictors of hypoglycemic episodes included African American race (relative risk [RR], 2.13) and low serum albumin level (RR, 1.92 per 100-g/L decrease); corticosteroid use was associated with a reduced risk of hypoglycemic episodes (RR, 0.32; P<.05). Independent predictors of hyperglycemic episodes included female gender (RR, 1.67), severity of illness (RR, 1.22 per 10 Acute Physiology and Chronic Health Evaluation III units), severe diabetic complications (RR, 2.32), high admission glucose level (RR, 1.33 per 5.5 mmol/L), admission for infectious disease (RR, 2.14), and corticosteroid use (RR, 3.74; P<.05). Of 171 patients, 130 (76%) were placed on a sliding scale insulin regimen. When used alone, sliding scale insulin regimens were associated with a 3-fold higher risk of hyperglycemic episodes compared with individuals following no pharmacologic regimen (RRs, 2.85 and 3.25, respectively; P<.05). Conclusions: Suboptimal glycemic control is common in medical inpatients with diabetes mellitus. The risk of suboptimal control is associated with selected demographic and clinical characteristics, which can be ascertained at hospital admission. Although sliding scale insulin regimens are prescribed for the majority of inpatients with diabetes, they appear to provide no benefit; in fact, when used without a standing dose of intermediate-acting insulin, they are associated with an increased rate of hyperglycemic episodes.
引用
下载
收藏
页码:545 / 552
页数:8
相关论文
共 50 条
  • [1] Glycemic control and length of hospital stay in patients with diabetes mellitus treated with sliding scale insulin
    Mellish, D
    Shin, J
    Castro, J
    El-Athath, F
    Serebnitsky, I
    Shatzkes, J
    Kane, J
    Bleicher, M
    Bubb, B
    Aneja, A
    Muniyappa, G
    Joseph, L
    Williams, R
    McFarlane, S
    DIABETES, 2003, 52 : A266 - A266
  • [2] Use of insulin to improve glycemic control in diabetes mellitus
    Dandona, Paresh
    Chaudhuri, Ajay
    Ghanim, Husam
    Mohanty, Priya
    CARDIOVASCULAR DRUGS AND THERAPY, 2008, 22 (03) : 241 - 251
  • [3] Use of Insulin to Improve Glycemic Control in Diabetes Mellitus
    Paresh Dandona
    Ajay Chaudhuri
    Husam Ghanim
    Priya Mohanty
    Cardiovascular Drugs and Therapy, 2008, 22 : 241 - 251
  • [4] Utility of Sliding Scale Insulin on Inpatient Glycemic Care of Type 2 Diabetes Mellitus
    Arao, Kevin A.
    Ebadi, Farha N.
    Capistrano, Maria Christina Victoria M.
    Chen, Kenneth K.
    DIABETES, 2020, 69
  • [5] Insulin Regimen and Glycemic Control in People with Type 2 Diabetes Mellitus
    Arunachalam, Amar
    Garg, Rajesh
    DIABETES, 2021, 70
  • [6] Insulin Therapy for Maximal Glycemic Control in Type 2 Diabetes Mellitus
    Spellman, Craig W.
    JOURNAL OF THE AMERICAN OSTEOPATHIC ASSOCIATION, 2007, 107 (07): : 260 - 269
  • [7] The role of insulin glulisine to improve glycemic control in children with diabetes mellitus
    Lih, Anna
    Hibbert, Emily
    Wong, Tang
    Girgis, Christian M.
    Garg, Nidhi
    Carter, John N.
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2010, 3 : 403 - 412
  • [8] Inpatient Glycemic Control With Sliding Scale Insulin in Noncritical Patients With Type 2 Diabetes: Who Can Slide?
    Migdal, Alexandra L.
    Fortin-Leung, Charlie
    Pasquel, Francisco
    Wang, Heqiong
    Peng, Limin
    Umpierrez, Guillermo E.
    JOURNAL OF HOSPITAL MEDICINE, 2021, 16 (08) : 462 - 468
  • [9] Differences in Glycemic Control for Inpatients with Type 1 Diabetes on Insulin Pump Versus Subcutaneous Insulin Therapy
    Ye, Yuting
    Acevedo-Mendez, Bernardo A.
    Izard, Stephanie
    Myers, Alyson K.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2024, 39 (10) : 1895 - 1900
  • [10] Evaluation of the effectiveness of sliding scale insulin for glycemic control in the home care setting
    Salek, Sam
    Gill, Navneet
    Gates, Brian
    Rice, Luke
    Weeks, Douglas
    PHARMACY WORLD & SCIENCE, 2008, 30 (05): : 709 - 709